The Immigration Services Agency of Japan has announced a new requirement for mid- to long-term visa applicants to undergo mandatory tuberculosis (TB) screening. This initiative aims to prevent the spread of TB by ensuring that visa applicants from specific countries undergo medical checks before entering Japan.
Who Will Be Affected?
The new TB screening requirement applies to mid- to long-term visa applicants, with some exceptions. The following visa categories are exempt from this requirement:- Specified Skilled Worker visas
- Government-funded exchange program participants
- Nurse, social worker, or helper visas under the Economic Partnership Agreement and similar government programs
Validity of the TB Test Certificate
The issued TB test certificate will be valid for 180 days from the date of testing. Applicants should ensure that their certificate remains valid throughout the application process to avoid delays.Implementation Timeline by Country
The screening requirement will be gradually introduced for different nationalities, with specific deadlines:- Philippines and Nepal: TB screening starts March 24, 2025. The test certificate will be required for COE applications from June 23, 2025.
- Vietnam: TB screening begins May 26, 2025. The test certificate will be required from September 1, 2025.
- Indonesia, Myanmar, and China: The implementation schedule is still under discussion, and further updates are expected.
Impact on Visa Applicants
This new requirement introduces an additional step in the visa application process for affected individuals. Applicants must ensure they complete the medical examination at an approved facility within the designated timeframe to prevent delays in their visa approval process.Pros and Cons Summary
Pros:- Enhances public health safety by reducing the risk of TB transmission.
- Aligns Japan’s immigration policies with global health protocols.
- Provides clarity on visa medical requirements for applicants from high-risk regions.
- Adds an extra step to the visa application process, potentially causing delays.
- Requires applicants to travel to designated medical facilities for testing.
- Limited initial information on implementation for certain countries (Indonesia, Myanmar, China), leading to uncertainty for affected applicants.